Trial Profile
A phase 1 study of combination chemotherapy for hepatocellular carcinoma using Miripla (SM11355) and IA-call (DDP-H)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Miriplatin (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics
- 19 May 2016 New trial record